Literature DB >> 15853177

Heparin-induced thrombocytopenia: principles for early recognition and management.

John R Bartholomew1, Susan M Begelman, Amjad Almahameed.   

Abstract

Heparin-induced thrombocytopenia (HIT) is a potentially devastating complication of therapy with either unfractionated or low-molecular-weight heparin. Thrombocytopenia is no longer essential for the diagnosis of HIT, since a 50% drop in the platelet count may be a more specific indicator. Once HIT is clinically suspected, heparin should be stopped immediately and direct thrombin inhibitor therapy started; waiting for laboratory confirmation may be catastrophic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15853177     DOI: 10.3949/ccjm.72.suppl_1.s31

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  3 in total

Review 1.  Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia.

Authors:  Phu Ngoc Tran; Minh-Ha Tran
Journal:  Clin Appl Thromb Hemost       Date:  2017-03-06       Impact factor: 2.389

2.  Pharmacodynamic and efficacy profile of TGN 255, a novel direct thrombin inhibitor, in canine cardiopulmonary bypass and simulated mitral valve repair.

Authors:  David A Nelson; Katherine T Nelson; Matthew W Miller; Robert Dupe; Suresh B Chahwala; Anthony Kennedy; Chaman Chander; Theresa W Fossum
Journal:  J Extra Corpor Technol       Date:  2008-06

3.  Heparin-induced thrombocytopenia: 2008 update.

Authors:  John R Bartholomew
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.